RESMED INC

RMD · Large cap · 0 articles

Financial highlights

Metric	FY 06/30/25	FY 06/30/24	FY 06/30/23	FY 06/30/22	FY 06/30/21
Income Statement
Revenue	$5.1B	$4.7B	$4.2B	$3.6B	$3.2B
Cost of revenue	$2.1B	$2.0B	$1.9B	$1.6B	$1.4B
Gross profit	$3.1B	$2.7B	$2.4B	$2.0B	$1.8B
Selling, general & administrative	$991.0M	$917.1M	$874.0M	$737.5M	$670.4M
Research and development	$331.3M	$307.5M	$287.6M	$253.6M	$225.3M
Operating expenses	$1.4B	$1.3B	$1.2B	$1.0B	$935.4M
Operating income	$1.7B	$1.3B	$1.1B	$1.0B	$903.7M
Interest expense	—	—	—	—	$24.0M
Pretax income	$1.7B	$1.3B	$1.1B	$960.5M	$883.7M
Income tax expense	$276.8M	$243.8M	$204.1M	$181.0M	$409.2M
Net income	$1.4B	$1.0B	$897.6M	$779.4M	$474.5M
Balance Sheet
Cash and equivalents	$1.2B	$238.4M	$227.9M	$273.7M	$295.3M
Current assets	$3.5B	$2.4B	$2.4B	$1.9B	$1.6B
Total assets	$8.2B	$6.9B	$6.8B	$5.1B	$4.7B
Current liabilities	$1.0B	$910.7M	$758.5M	$689.3M	$911.8M
Total liabilities	$2.2B	$2.0B	$2.6B	$1.7B	$1.8B
Total debt	$668.3M	$707.2M	$1.4B	$775.2M	$655.4M
Stockholders' equity	$6.0B	$4.9B	$4.1B	$3.4B	$2.9B
Cash Flow Statement
Cash from operations	$1.8B	$1.4B	$693.3M	$351.1M	$736.7M
Depreciation and amortization	$198.5M	$176.9M	$165.2M	$159.6M	$156.8M
Stock-based compensation	$91.7M	$80.2M	$71.1M	$65.3M	$63.9M
Capital expenditure	$89.9M	$99.5M	$119.7M	$134.8M	$102.7M
Free cash flow	$1.7B	$1.3B	$573.6M	$216.3M	$634.0M
Dividends paid	$310.9M	$282.3M	$258.3M	$245.3M	$226.7M
Share repurchases	$300.0M	$150.0M	$0	$0	—
Impairments	—	—	$0	$0	$0

Shares outstanding 145.1M · Free float 94.9%

Annual filing data through FY ended June 30, 2025; float as of July 11, 2026.